Skip to main content
Ajay Nooka, MD, Oncology, Atlanta, GA, Emory University Hospital Midtown

AjayKNookaMD

Oncology • Atlanta, GA

Associate Professor, Hematology and Medical Oncology, Emory University School of Medicine

Join to view full profile

Dr. Nooka is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nooka's full profile

Already have an account?

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011
  • Canton Medical Education Foundation
    Canton Medical Education FoundationResidency, Internal Medicine, 2005 - 2008
  • Andhra Medical College NTR
    Andhra Medical College NTRClass of 2000

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2009 - 2023
  • OH State Medical License
    OH State Medical License 2005 - 2008
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Response to Therapy and the Effectiveness of Treatment with Selinexor and Dexamethasone in Patients with Penta-Exposed Triple-Class Refractory Myeloma Who Had Plasmacy...
    Ajay K Nooka, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Comprehensive Investigation of White Blood Cell and Gene Expression Profiles As Risk Factors for Multiple Myeloma in African Americans
    Ajay K Nooka, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Efficacy and Safety of Daratumumab, Bortezomib, and Dexamethasone (D-Vd) Versus Bortezomib and Dexamethasone (Vd) in First Relapse Patients (pts) with Multiple Myeloma...
    Ajay K Nooka, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Influence of Cytogenetics in Patients with Relapsed Refractory Multiple Myeloma Treated with Oral Selinexor and Dexamethasone: A Post-Hoc Analysis of the STORM Study 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Evaluation of All Cause of Death after High Dose Chemotherapy and Autologous Stem Cell Transplant in Hodgkin Lymphoma and Non-Hodgkin Lymphoma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Phase II Trial of Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized with NFKB2 Rearrangement. (Proteasome Inhibitor NFKB2 Rearrang... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • Patients with Low-Risk Myeloma Could Prove Ideal for Daratumumab Therapy
    Patients with Low-Risk Myeloma Could Prove Ideal for Daratumumab TherapySeptember 26th, 2019
  • Winship Receives NCI Grant in Multiple Myeloma
    Winship Receives NCI Grant in Multiple MyelomaSeptember 10th, 2018
  • OncLive® Presents State of the Science Summit™ on Hematologic Malignancies
    OncLive® Presents State of the Science Summit™ on Hematologic MalignanciesOctober 31st, 2019
  • Join now to see all

Hospital Affiliations

Dr. Ajay Nooka, Dr. Ajay Nooka, MD, Dr. A Nooka, Dr. Ajay K Nooka